Guideline of prophylactic use of Kampo Medicine for new coronavirus infection (COVID-19)【2021/3/24 updated 】

2020年04月30日

About the Guideline

This is a summary of Prophylactic use of Kampo Medicine for the current epidemic of the new corona infection (COVID-19).

In preparing this " Guideline of prophylactic use of Kampo Medicine for new coronavirus infection (COVID-19)" (hereinafter referred to as " guideline"), the opinions of many experts both in Japan and abroad, including the specialist who spearheaded traditional medicine in Wuhan City, have been referred to and summarized with a focus on Kampo medicine available in Japan.

Download the Guideline

Guideline of prophylactic use of Kampo Medicine for new coronavirus infection (COVID-19)

Author

Kenji Watanabe (Representative director, Kampo Industralization Consortium, Eminent Professor, Yokohama University of Pharmacy)
Sung Joon Kim (Yokohama University of Pharmacy)
Chikano Shibayama (Daiichi University of Pharmacy)
Jun Imai (President, The Japan Kampo Medicine Association,)

Contact

Mediva inc.【Secretariat】
ml-kampo@kampo-promotion.jp
03-6447-9822（Ogura、Koike、Meguro、Bao)